Thomas E. Lad, MD

John H. Stroger, Jr. Hospital ...Chicago, Illinois - 60612-3785 (312-791-2953) |
- CLINICAL TRIALS 9
- CONDITIONS15
- INTERVENTIONS23
- SINCE2007

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
April 2009 - December 2011

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
October 2009 - September 2012

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Paclitaxel Cisplatin and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
June 2008 - December 2015

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
November 2007 - January 2014

Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
July 2009 - December 2010

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015

Carboplatin Paclitaxel and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
January 2010 - July 2012
Breast Neoplasms
Lung Neoplasms
Carcinoma
Liver Neoplasms
Carcinoma, Hepatocellular
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Carcinoma, Small Cell
Uterine Cervical Neoplasms
Radiation Injuries
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Placebo
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Radiation Therapy
Pemetrexed Disodium
3-Dimensional Conformal Radiation Therapy
Doxorubicin Hydrochloride
Trastuzumab
Cixutumumab
Sorafenib Tosylate
Cetuximab
Etoposide Phosphate
Mitomycin C
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Hedgehog Antagonist Gdc-0449
Vinorelbine Ditartrate



